Company Overview of The Jackson Laboratory
The Jackson Laboratory conducts mammalian genetics research in the United States. It offers scientific services and genetic resources to laboratories internationally, and educates students of various ages through courses, internships, and programs. The company also provides scientific resources, techniques, software, and data to scientists internationally. It offers high school internships, pre and post-doctoral opportunities, and collaborative education programs. The company discovers genetic basis for preventing, treating, and curing human diseases in the areas of cancers, computational biology and bioinformatics, developmental and reproductive biology, immunology, metabolic diseases, and ...
600 Main Street
Bar Harbor, ME 04609
Founded in 1929
Key Executives for The Jackson Laboratory
Chief Executive Officer and President
Chief Operating Officer and Executive Vice President
Director of Genetic Resource Science
Chair of Research and Associate Director
Compensation as of Fiscal Year 2013.
The Jackson Laboratory Key Developments
Karolina Palucka Joins The Jackson Laboratory as Professor and Associate Director of Cancer Immunology
Feb 21 14
A. Karolina Palucka, M.D., Ph.D., will join The Jackson Laboratory for Genomic Medicine faculty as professor and associate director of cancer immunology. Science magazine recognized cancer immunotherapy as the 'Breakthrough of the Year' in 2013, and Palucka is one of the leaders in this field. Her research exploits dendritic cells, which control the body’s immune response to tumors, as the basis for new vaccines against melanomas and other human cancers. In a recent interview in the journal Nature, Palucka described how she used this approach to treat the pancreatic cancer of Nobel prizewinner Ralph M. Steinman using dendritic cells—the very cells Steinman and colleagues had discovered.
Life Technologies Corporation and The Jackson Laboratory Sign agreement for TAL Technology
Nov 22 13
Life Technologies Corporation and The Jackson Laboratory, or JAX have signed an agreement enabling JAX to use Life's Transcription Activator-Like Effector technology, or TALs, to generate and market novel mouse disease models. Jackson Laboratory will also establish a program to maintain and distribute TAL-modified mice developed by researchers in pharma and academic labs. Life Technologies' patented TAL technology, marketed as GeneArt Precision TALs, enables targeting and binding of DNA sequences with high precision, permitting researchers to generate genetically modified mice quickly, easily and reliably. This relationship with Life Technologies will advance both and Life Technologies' goals in developing animal models that will advance understanding of human disease and help in the development of novel drugs.
The Jackson Laboratory, Inc. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013
Feb 7 13
The Jackson Laboratory, Inc. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 . Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|